
Refoxy Pharmarevenue
Cologne, North Rhine-Westphalia, GermanyFounded 2020CEO Henrik Shimony
Refoxy Pharma is a pre-clinical stage biotechnology company developing medicines for the treatment and prevention of aging and aging-associated diseases.
Refoxy Pharma revenue
Refoxy Pharma has not published its revenue. Growjo puts it at about $23.1M a year (September 2025).
| As of | Revenue | Source |
|---|---|---|
| Sep 2025 | $23.1MEST | Growjo estimate |
Refoxy Pharma CEO & employees
Henrik Shimony is CEO of Refoxy Pharma. Refoxy Pharma has 11 employees (September 2025, LinkedIn).
Refoxy Pharma FAQ
What is Refoxy Pharma's revenue?
Growjo estimates Refoxy Pharma's revenue at about $23.1M a year (September 2025). The company hasn't published its own figure.
How many employees does Refoxy Pharma have?
Refoxy Pharma has 11 employees as of September 2025, according to LinkedIn.
Who is the CEO of Refoxy Pharma?
Henrik Shimony is the CEO of Refoxy Pharma.
Categories
How this page is sourced
1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Refoxy Pharma? Join the podcast